Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema-Reference-Cited by-同舟云学术

Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema

Published:2018-10-18 Issue:20 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Rockson Stanley G.^ORCID,Tian Wen^ORCID,Jiang Xinguo^ORCID,Kuznetsova Tatiana,Haddad Francois,Zampell Jamie,Mehrara Babak,Sampson Joshua P.,Roche Leslie,Kim Jinah,Nicolls Mark R.^ORCID

Funder

Stanford University

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/123775/files/pdf

Reference33 articles.

1. Update on the Biology and Treatment of Lymphedema

2. New developments in clinical aspects of lymphatic disease

3. Lymphedema beyond breast cancer

4. Estimating the Population Burden of Lymphedema

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04

2. Lymphatic endothelial cell-targeting lipid nanoparticles delivering VEGFC mRNA improve lymphatic function after injury;2024-07-31

3. Molecular pathophysiology of secondary lymphedema;Frontiers in Cell and Developmental Biology;2024-07-08

4. Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities;Frontiers in Cardiovascular Medicine;2024-06-10

5. A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema;Genes;2024-06-04